141 related articles for article (PubMed ID: 11571569)
1. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.
Xu R; Janson CG; Mastakov M; Lawlor P; Young D; Mouravlev A; Fitzsimons H; Choi KL; Ma H; Dragunow M; Leone P; Chen Q; Dicker B; During MJ
Gene Ther; 2001 Sep; 8(17):1323-32. PubMed ID: 11571569
[TBL] [Abstract][Full Text] [Related]
2. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
3. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
4. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
5. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
Furler S; Paterna JC; Weibel M; Büeler H
Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
[TBL] [Abstract][Full Text] [Related]
6. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
7. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain.
Paterna JC; Moccetti T; Mura A; Feldon J; Büeler H
Gene Ther; 2000 Aug; 7(15):1304-11. PubMed ID: 10918501
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of AAV-mediated glial cell-line derived neurotrophic factor expression by using improved Tet-on trans-activator].
Chen T; Li XG; Wu CY; Takashi O; Keiya O
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):405-8. PubMed ID: 15854532
[TBL] [Abstract][Full Text] [Related]
9. Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES.
Delluc-Clavières A; Le Bec C; Van den Berghe L; Conte C; Allo V; Danos O; Prats AC
Gene Ther; 2008 Aug; 15(15):1090-8. PubMed ID: 18369321
[TBL] [Abstract][Full Text] [Related]
10. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.
Wang CY; Wang S
Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097
[TBL] [Abstract][Full Text] [Related]
11. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
[TBL] [Abstract][Full Text] [Related]
12. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
[TBL] [Abstract][Full Text] [Related]
13. Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors.
Cucchiarini M; Ren XL; Perides G; Terwilliger EF
Gene Ther; 2003 Apr; 10(8):657-67. PubMed ID: 12692594
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats.
Müller OJ; Schinkel S; Kleinschmidt JA; Katus HA; Bekeredjian R
Gene Ther; 2008 Dec; 15(23):1558-65. PubMed ID: 18615116
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus vectors for short hairpin RNA expression.
Grimm D; Pandey K; Kay MA
Methods Enzymol; 2005; 392():381-405. PubMed ID: 15644194
[TBL] [Abstract][Full Text] [Related]
17. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
[TBL] [Abstract][Full Text] [Related]
18. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
20. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR.
Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC
Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]